Abstract

To fulfill an FDA requirement that new diabetes therapies demonstrate cardiovascular safety, investigators conducted an industry-sponsored,

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call